These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 15944311

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B, Lu S, Tong Q, Kong Q, Lou D.
    Vaccine; 2013 Sep 23; 31(41):4578-84. PubMed ID: 23928460
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The GRA17 Parasitophorous Vacuole Membrane Permeability Pore Contributes to Bradyzoite Viability.
    Paredes-Santos T, Wang Y, Waldman B, Lourido S, Saeij JP.
    Front Cell Infect Microbiol; 2019 Sep 23; 9():321. PubMed ID: 31572690
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
    Seng S, Makala LH, Yokoyama M, Lim C, Choi YH, Suzuki N, Toyoda Y, Nagasawa H.
    Pathobiology; 2004 Sep 23; 71(3):144-51. PubMed ID: 15051927
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
    Lu G, Zhou A, Meng M, Wang L, Han Y, Guo J, Zhou H, Cong H, Zhao Q, Zhu XQ, He S.
    BMC Infect Dis; 2014 Dec 20; 14():3862. PubMed ID: 25527277
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
    Kang H, Remington JS, Suzuki Y.
    J Immunol; 2000 Mar 01; 164(5):2629-34. PubMed ID: 10679102
    [Abstract] [Full Text] [Related]

  • 35. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.
    Yang CD, Chang GN, Chao D.
    Parasitol Res; 2004 Jan 01; 92(1):58-64. PubMed ID: 14605877
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector.
    Tomita T, Mukhopadhyay D, Han B, Yakubu R, Tu V, Mayoral J, Sugi T, Ma Y, Saeij JPJ, Weiss LM.
    mBio; 2021 May 18; 12(3):. PubMed ID: 34006649
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS, Xie ZX, Chen QX, Chen S, Zhang LF.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct 30; 28(5):359-63. PubMed ID: 21351549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.